Federal Health Watchdog Projects $5.56 Billion in Recoveries and Savings, Despite Enforcement Hitting Two-Year Low

The federal watchdog for the Department of Health and Human Services (DHS) has projected a recovery and savings of $5.56 billion over six months.

The Department of Health and Human Services Office of Inspector General (OIG) declared on Monday, in its semiannual report from October to March, that it generated $12.70 in recoveries and expected savings for every dollar spent, reported Reuters.

The total was driven in part by several major enforcement actions, including the 15-year prison sentence of a telemedicine software executive tied to a $1 billion fraud scheme, as well as $674 million in settlements with affiliates of Kaiser Permanente and CVS Health Corp‘s (NYSE:CVS) Aetna over allegations of inflated Medicare Advantage billing.

The watchdog that it had prohibited 1,212 individuals and companies from federal programs, even though its enforcement activity has hit a two-year low, as per the report.

Authored by Inspector General T. March Bell, the report marks the first comprehensive assessment released during his tenure. Bell, a Republican lawyer, won Senate confirmation in December and previously headed a House investigation into Planned Parenthood.

The number of criminal referrals declined to 1,168 from 1,451. Meanwhile, the report’s “total monetary impact”—a metric introduced in early 2025- has varied significantly, falling from $16.61 billion to $2.43 billion before rebounding to $5.56 billion. The report notes that these figures reflect ordered or agreed repayments and projected savings, not the amount actually recovered.

Medicaid Fraud Crackdown Grows

The crackdown on Medicaid fraud has been a focus of the health department, with CMS Administrator Mehmet Oz announcing a nationwide crackdown on Medicaid fraud in April, ordering all 50 states to submit provider revalidation plans within 30 days or face intensified federal audits.

In June, the Justice Department sued New York state officials and Public Partnerships LLC, accusing them of facilitating fraud in a $10 billion Medicaid home-care program serving disabled patients.

Meanwhile, the Supreme Court also rejected a Medicaid fraud appeal by Eli Lilly and Co. (NYSE:LLY) in May, further highlighting the government’s commitment to combating fraud. The company argued the law wrongly lets private whistleblowers sue on the government’s behalf for a share of recoveries. In fiscal 2024, whistleblowers filed a record 979 False Claims Act cases, leading to more than $2.9 billion in settlements and judgments, according to the U.S. Department of Justice.

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Photo courtesy: Shutterstock